KemPharm

+$1.27 (+9.51%) Today

+$0.37 (+2.53%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell KemPharm and other stocks, options, and ETFs commission-free!

About KMPH

KemPharm, Inc. Common Stock, also called KemPharm, is a clinical-stage specialty pharmaceutical company, which engages in the discovery and development of proprietary prodrugs.

CEO

Travis C. Mickle

Employees

Headquarters

Celebration, Florida

Founded

2006

KMPH Key Statistics

Market Cap

416.78M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

982.67K

High Today

$15.50

Low Today

$13.36

Open Price

$13.38

Volume

2.31M

52 Week High

$18.15

52 Week Low

$5.86

KMPH News

BenzingaJun 10

Why This News Could Help KemPharm Stock Break Out: A Technical Analysis

KemPharm Inc. (NASDAQ:KMPH) shares moved higher Thursday after it was announced the company is being added to the Russell 3000 and Russell 2000 indexes based on

KMPH Earnings

-$1.61

-$1.05

-$0.50

$0.06

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Estimated

— per share

Actual

Expected Aug 12, After Hours